Immunohistochemical staining of ERG and SOX9 as potential biomarkers of docetaxel response in patients with metastatic castration-resistant prostate cancer

We aimed to evaluate ERG and SOX9 as potential biomarkers of docetaxel response in metastatic castration-resistant prostate cancer (mCRPC) patients. Seventy-one mCRPC patients were evaluated. Tissue microarrays were constructed and immunohistochemistry was performed. Treatment response was assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Wan, Kwon, Ghee Young, Kim, Jeong Hoon, Lim, Joung Eun, Jeon, Hwang Gyun, Il Seo, Seong, Jeon, Seong Soo, Choi, Han Yong, Jeong, Byong Chang, Lee, Hyun Moo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347800/
https://www.ncbi.nlm.nih.gov/pubmed/27863438
http://dx.doi.org/10.18632/oncotarget.13407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347800/
https://www.ncbi.nlm.nih.gov/pubmed/27863438
http://dx.doi.org/10.18632/oncotarget.13407

Ejemplares similares